These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33933013)

  • 1. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms.
    Neidell MJ; Cohen B; Furuya Y; Hill J; Jeon CY; Glied S; Larson EL
    Clin Infect Dis; 2012 Sep; 55(6):807-15. PubMed ID: 22700828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
    Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections.
    Nelson RE; Schweizer ML; Perencevich EN; Nelson SD; Khader K; Chiang HY; Chorazy ML; Blevins A; Ward MA; Samore MH
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1212-8. PubMed ID: 27406609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
    Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
    J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region.
    Alothman A; Al Thaqafi A; Al Ansary A; Zikri A; Fayed A; Khamis F; Al Salman J; Al Dabal L; Khalife N; AlMusawi T; Alfouzan W; El Zein S; Kotb R; Ghoneim Y; Kanj SS
    Int J Infect Dis; 2020 Dec; 101():249-258. PubMed ID: 33031939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.
    Mauldin PD; Salgado CD; Hansen IS; Durup DT; Bosso JA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):109-15. PubMed ID: 19841152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
    Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
    BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study.
    Osme SF; Almeida APS; Lemes MF; Barbosa WO; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
    J Hosp Infect; 2020 Oct; 106(2):303-310. PubMed ID: 32693085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections.
    Zhang Y; Du M; Johnston JM; Andres EB; Suo J; Yao H; Huo R; Liu Y; Fu Q
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):137. PubMed ID: 32811557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital-acquired infections in Belgian acute-care hospitals: an estimation of their global impact on mortality, length of stay and healthcare costs.
    Vrijens F; Hulstaert F; Devriese S; van de Sande S
    Epidemiol Infect; 2012 Jan; 140(1):126-36. PubMed ID: 21320376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection.
    Lü Y; Cai MH; Cheng J; Zou K; Xiang Q; Wu JY; Wei DQ; Zhou ZH; Wang H; Wang C; Chen J
    Antimicrob Resist Infect Control; 2018; 7():99. PubMed ID: 30116526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.
    Hsu JL; Siroka AM; Smith MW; Holodniy M; Meduri GU
    Int J Infect Dis; 2011 Jun; 15(6):e382-7. PubMed ID: 21393043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study.
    Touat M; Opatowski M; Brun-Buisson C; Cosker K; Guillemot D; Salomon J; Tuppin P; de Lagasnerie G; Watier L
    Appl Health Econ Health Policy; 2019 Jun; 17(3):381-389. PubMed ID: 30506456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients.
    Glance LG; Stone PW; Mukamel DB; Dick AW
    Arch Surg; 2011 Jul; 146(7):794-801. PubMed ID: 21422331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.
    Maseda E; Ramírez S; Picatto P; Peláez-Peláez E; García-Bernedo C; Ojeda-Betancur N; Aguilar G; Forés B; Solera-Marín J; Aliaño-Piña M; Tamayo E; Ramasco F; García-Álvarez R; González-Lisorge A; Giménez MJ; Suárez-de-la-Rica A;
    PLoS One; 2019; 14(9):e0223092. PubMed ID: 31557256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.